Senator Elizabeth Warren of the United States recently wrote to the head of the United States Patent and Trademark Office to express her concern that continued efforts to patent Merck & Co.'s (MRK.N) blockbuster cancer treatment Keytruda may constitute an abuse of the patent system.
In a letter sent on Wednesday and seen by Reuters, Warren argued to Kathi Vidal, director of the United States Patent and Trademark Office (PTO),....
Tags : Patent and Trademark, Senator Elizabeth Warren, Merck & Co.'s (MRK.N), Keytruda,
comments (0)